Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 10

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Oncol. Oct 15, 2012; 4(10): 207-215
Published online Oct 15, 2012. doi: 10.4251/wjgo.v4.i10.207

Table 3 Patient outcomes n (%)

Recurrence status (n= 169)
Recurred	124 (73.3)
No recurrence	45 (26.6)
Recurrence location (n = 124)
Local	21 (16.9)
Distant	66 (53.2)
Local and distant	7 (5.6)
Unknown	30 (24.2)
Overall survival time (mo)	15.1 (8.0-33.5)¹
Time to recurrence (mo)	9.8 (5.1-21.1)¹
Disease-related survival status (n = 169)
Death from disease	104 (62.5)
Death from other causes	19 (11.2)
Alive with disease	21 (12.4)
Alive with no disease	25 (14.8)

¹Median (interquartile range).

Citation: Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215
URL: https://www.wjgnet.com/1948-5204/full/v4/i10/207.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i10.207

Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215 [PMID: 23444312 DOI: 10.4251/wjgo.v4.i10.207]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.